Digipath Inc (DIGP)

[europa7]

CANNMED 2019 Safety Panel: The Future of Cannabis Testing

FYI - interesting discussion by panelists on testing...especially input by Dr. Orser...cheers.

Source: posted Oct 2019 by Medicinal Genomics...

https://cannmedevents.com/2019-videos/

https://cannmedevents.com/abstractpresenter-cindy-orser/

Cindy Orser, PhD
Chief Scientific Officer
Digipath, Inc. & DigiPath Labs
PANELIST

https://cannmedevents.com/

Why CannMed?

"CannMed is the leading cannabis science conference, showcasing the greatest minds in cannabis science, medicine, cultivation, and safety. With a booming industry anticipated to exceed $500B by 2028, understanding the complex science and its medical benefits for patients in need is how the CannMed conference series was born. Since the inaugural event at Harvard Medical School in 2016, CannMed has become the platform for the leading minds in cannabis to share their latest findings and unveil breakthrough technologies. Medicinal Genomics invites you Pasadena, September 21-22, for CannMed 2020, so you can experience firsthand why CannMed continues to lead the way in cannabis science conferences."